ArticleInvestigative ophthalmology & visual science2025
Abnormal Splicing in the Final Intron of PRX Results in Dominant Congenital Cataract Without Neurological Phenotype.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
Abstract
Purpose: Disrupted lens development can result in congenital cataract. Despite identifying over 50 genes linked to non-syndromic pediatric cataract, a causative mutation is found in only about 50% of affected families. Methods: Exome and/or genome sequencing was undertaken in families with unexplained congenital cataract. Results: Sequencing revealed heterozygous variants affecting splicing of the final intron of PRX in seven individuals from four families. PRX encodes periaxin, a protein necessary for the maintenance of peripheral nerve myelin and the proper organization of the lens cortex adherens junction. PRX has two major isoforms, differing in their final exon(s). For PRXb (L-PRX, 1461 amino acids), a small intron 6 separates exons 6 and 7; in PRXa (S-PRX, 147 amino acids), the intron is retained, generating a larger exon 6a but introducing an earlier stop codon. Loss-of-function variants affecting L-PRX (or both isoforms) cause recessive neurological phenotypes without cataract. The dominant cataract alleles identified here occur within the splice region of intron 6 and are predicted to cause abnormal splicing of PRXb (L-PRX). RNA sequencing confirmed aberrant splicing for all identified variants, including retention of intron 6, which ultimately results in a switch to the S-PRX isoform, and/or utilization of alternate donor or acceptor sites yielding small in-frame deletions in L-PRX. Conclusions: Splicing defects leading to the replacement of L-PRX by S-PRX and/or the presence of an aberrant L-PRX exert a significant negative effect on lens development, possibly through a gain-of-function or dominant-negative mechanism distinct from the one implicated in recessive neurological phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.